<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The present investigation was designed to study the cardioprotective effects of nicorandil and <z:chebi fb="0" ids="8228">pioglitazone</z:chebi> preconditioning in <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">myocardial ischemia</z:e>/reperfusion-induced hemodynamic, biochemical and histological changes in rats </plain></SENT>
<SENT sid="1" pm="."><plain>Oral doses of nicorandil (3 or 6 mg/kg) and <z:chebi fb="0" ids="8228">pioglitazone</z:chebi> (10 or 20mg/kg) were administered once daily for 5 consecutive days </plain></SENT>
<SENT sid="2" pm="."><plain>Rats were then subjected to <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">myocardial ischemia</z:e>/reperfusion (40 min/10 min) </plain></SENT>
<SENT sid="3" pm="."><plain>Heart rate and <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> were recorded during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion progress </plain></SENT>
<SENT sid="4" pm="."><plain>At the end of reperfusion, plasma <z:chebi fb="2" ids="16919">creatine</z:chebi> kinase-MB activity and total nitrate/<z:chebi fb="95" ids="16301">nitrite</z:chebi> were determined </plain></SENT>
<SENT sid="5" pm="."><plain>In addition, <z:chebi fb="4" ids="24996">lactate</z:chebi>, <z:chebi fb="1" ids="16708">adenine</z:chebi> <z:chebi fb="9" ids="36976">nucleotides</z:chebi>, <z:chebi fb="0" ids="33202">thiobarbituric acid</z:chebi> reactive substances, reduced <z:chebi fb="0" ids="16856">glutathione</z:chebi> and myeloperoxidase activity were estimated in the heart left ventricle </plain></SENT>
<SENT sid="6" pm="."><plain>Finally, histological examination was performed to visualize the protective cellular effects of different pretreatments </plain></SENT>
<SENT sid="7" pm="."><plain>Nicorandil (3 or 6 mg/kg) was effective in attenuating the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion-induced <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo>, <z:chebi fb="2" ids="16919">creatine</z:chebi> kinase-MB release, <z:chebi fb="4" ids="24996">lactate</z:chebi> accumulation and <z:mp ids='MP_0003674'>oxidative stress</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>Nicorandil (3 mg/kg) was more effective in improving the energy production and lowering the elevated myeloperoxidase activity </plain></SENT>
<SENT sid="9" pm="."><plain>Both doses of <z:chebi fb="0" ids="8228">pioglitazone</z:chebi> (10 or 20 mg/kg) were equally effective in reducing <z:chebi fb="4" ids="24996">lactate</z:chebi> accumulation and completely counteracting the <z:mp ids='MP_0003674'>oxidative stress</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain><z:chebi fb="0" ids="8228">Pioglitazone</z:chebi> (10 mg/kg) was more effective in improving energy production and reducing <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo>, plasma <z:chebi fb="2" ids="16919">creatine</z:chebi> kinase-MB release and total nitrate/<z:chebi fb="95" ids="16301">nitrite</z:chebi> </plain></SENT>
<SENT sid="11" pm="."><plain>It seems that selective <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> K(ATP) channel opening by lower doses of nicorandil and <z:chebi fb="0" ids="8228">pioglitazone</z:chebi> in the present study provided more cardioprotection against <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> and biochemical changes induced by <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion </plain></SENT>
<SENT sid="12" pm="."><plain>Histological examination revealed also better improvement by the lower dose of nicorandil than that of <z:chebi fb="0" ids="8228">pioglitazone</z:chebi> </plain></SENT>
</text></document>